期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 19, 期 1, 页码 301-309出版社
IOS PRESS
DOI: 10.3233/JAD-2010-1236
关键词
Alzheimer's disease; biomarkers; cerebrospinal fluid; Lewy body disease; vascular cognitive impairment
资金
- Nancy and Buster Alvord Endowment
- NIH [AG05136, AG08017]
- Department of Veterans Affairs
- NATIONAL INSTITUTE ON AGING [P30AG008017, P50AG005136] Funding Source: NIH RePORTER
Given the magnitude of the public health problem of dementia in the elderly, there is a pressing need for research, development, and timely application of biomarkers that will identify latent and prodromal illness as well as dementia. Although identification of risk factors and neuroimaging measures will remain key to these efforts, this review focuses on recent progress in the discovery, validation, and standardization of cerebrospinal fluid (CSF) biomarkers, small molecules and macromolecules whose CSF concentration can aid in diagnosis at different stages of disease as well as in assessment of disease progression and response to therapeutics. A multimodal approach that brings independent information from risk factor assessment, neuroimaging, and biomarkers may soon guide physicians in the early diagnosis and management of cognitive impairment in the elderly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据